(1S,5R)-N-methyl-N-[6-[4-(2-methyltriazol-4-yl)-1H-indazol-7-yl]pyridazin-3-yl]-8-azabicyclo[3.2.1]octan-3-amine
C22H25N9 — CID 156845361
Data last refreshed: (MolForge compound catalog, from PubChem)
About (1S,5R)-N-methyl-N-[6-[4-(2-methyltriazol-4-yl)-1H-indazol-7-yl]pyridazin-3-yl]-8-azabicyclo[3.2.1]octan-3-amine
(1S,5R)-N-methyl-N-[6-[4-(2-methyltriazol-4-yl)-1H-indazol-7-yl]pyridazin-3-yl]-8-azabicyclo[3.2.1]octan-3-amine (PubChem CID 156845361) has the molecular formula C22H25N9 and a molecular weight of 415.51 g/mol. Its IUPAC name is (1S,5R)-N-methyl-N-[6-[4-(2-methyltriazol-4-yl)-1H-indazol-7-yl]pyridazin-3-yl]-8-azabicyclo[3.2.1]octan-3-amine.
Molecular Properties
| Compound Name | (1S,5R)-N-methyl-N-[6-[4-(2-methyltriazol-4-yl)-1H-indazol-7-yl]pyridazin-3-yl]-8-azabicyclo[3.2.1]octan-3-amine |
|---|---|
| PubChem CID | 156845361 |
| Molecular Formula | C22H25N9 |
| Molecular Weight | 415.51 g/mol |
| Exact Mass | 415.22 |
| IUPAC Name | (1S,5R)-N-methyl-N-[6-[4-(2-methyltriazol-4-yl)-1H-indazol-7-yl]pyridazin-3-yl]-8-azabicyclo[3.2.1]octan-3-amine |
| SMILES | CN(c1ccc(-c2ccc(-c3cnn(C)n3)c3cn[nH]c23)nn1)C1C[C@H]2CC[C@@H](C1)N2 |
| InChI | InChI=1S/C22H25N9/c1-30(15-9-13-3-4-14(10-15)25-13)21-8-7-19(26-27-21)17-6-5-16(18-11-23-28-22(17)18)20-12-24-31(2)29-20/h5-8,11-15,25H,3-4,9-10H2,1-2H3,(H,23,28)/t13-,14+,15? |
| InChIKey | KNWXOUGLJCIMTR-YIONKMFJSA-N |
| XLogP | 2.53 |
| TPSA | 100.44 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 415.51 |
| LogP ≤ 5 | 2.53 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156845361 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.